...
首页> 外文期刊>癌と化学療法 >Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment
【24h】

Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment

机译:具有区域淋巴结转移的两种复发性乳腺癌,显示对曲妥珠单抗和紫杉醇治疗的完全反应

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We report two cases of recurrent breast cancer with regional lymph node metastases that responded completely to treatment with trastuzumab and paclitaxel. Case 1: A 52-year-old woman, who presented with left breast cancer, underwent mastectomy and axillary lymph node dissection in July 2002. Pathological findings were as follows: invasive ductal carcinoma (scirrhous type), 2.2 cm in size, histological grade 3, positive invasion to the lymphatic and blood vessels, negative nodal status (0/11), negative ER/PgR status, and overexpression of HER 2/neu. Left axillary lymph node metastasis was noted after five months, ie, in December 2002. Four cycles of chemotherapy with doxorubicin and cyclophosphamide were administered from January 2003; however, they were not effective. The patient showed a complete response after three months of chemotherapy with trastuzumab and paclitaxel. This treatment was stopped in September 2003. She has maintained a complete response for two and a half years and was not administered any further treatment as of February 2006. Case 2: A 59-year-old woman, who presented with right breast cancer, underwent mastectomy and axillary lymph node dissection in May 2002. Pathological findings were as follows: invasive ductal carcinoma (scirrhous type), 1.8 cm in size, histological grade 2, positive invasion to the lymphatic and blood vessels, negative nodal status (0/5), positive ER and uncertain PgR status, and overexpression of HER 2/neu. She had received adjuvant hormonal therapy with tamoxifen; however, a right supraclavicular lymph node metastasis was noted in October 2004. Treatment with exemestane was not effective. However, a complete response was observed with trastuzumab and paclitaxel for four months. She has maintained a complete response for six months and was not administered any further treatment as of February 2006.
机译:我们报告了两种患有区域淋巴结转移的复发性乳腺癌患者,这些淋巴结转移是用曲妥珠单抗和紫杉醇治疗的完全反应。案例1:一名52岁的女性,在2002年7月介绍左乳腺癌,接受乳房切除术和腋窝淋巴结解剖。病理学发现如下:侵入性导管癌(粗型),2.2厘米的大小,组织学等级3,对淋巴病和血管的阳性侵袭,阴性节点状态(0/11),负er / pgr状态,以及她的2 / neu的过度表达。左腋窝淋巴结转移在五个月后,即2002年12月,从2003年1月施用了四个与多柔比星和环磷酰胺的化疗循环;但是,它们没有效果。患者在用曲妥珠单抗和紫杉醇后三个月化疗后表现出完全反应。这项治疗于2003年9月停止。她保持了两年半的完全回应,并没有截至2006年2月的任何进一步治疗。案例2:一名59岁的女性,他呈现出右乳腺癌, 2002年5月的乳房切除术和腋窝淋巴结解剖。病理学发现如下:侵入性导管癌(粗糙型),尺寸为1.8厘米,组织学等级2,淋巴血管的阳性侵袭,阴性节点状态(0/5 )阳性ER和不确定的PGR状态,以及她的2 / Neu的过度表达。她接受了Tamoxifen的佐剂荷尔蒙治疗;然而,2004年10月指出的右上丙啶淋巴结转移。用20世纪期治疗无效。然而,用曲妥珠单抗和紫杉醇观察到完全反应四个月。她保持了六个月的完全回应,并没有截至2006年2月的任何进一步治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号